Chemotherapy for lung cancer is the therapy designed according to the symptoms, type of the cancerous stage, age of the patient, time of approach of the affected patient to the cancer specialist etc. In general both the attending physician and the patient should be aware of baseline technical information on the kind of chemotherapy for lung cancer now proposed.
Toxicity during chemotherapy for lung cancer
Toxicity due to the prolonged administration of chemotherapy has been documented in cancer hospitals of various countries and however, due to the open meetings in person or internet based forum or informative boards maintained in the web, the patients may attempt to acquire additional knowledge on these toxic effects that are likely to happen in them during their undergoing of chemotherapy for lung cancer.
Chemotherapy may include anti-cancerous drugs often in combination like cisplatin, which is often given by intra-venous route in patients with lung cancer. However, it is to be understood that the effects of chemotherapy for lung cancer depends more specifically on type of lung cancer and extent of its spread.
If metastasis is encountered extensively in organs like liver, kidney, bone etc. or if it is a small cell lung cancer, then the chemotherapy for lung cancer may not be much successful but however, one has to alleviate the signs of pain in the patient by the lung cancer and hence, along with combination chemotherapy for lung cancer, supportive therapy is also required.
Chemotherapy for lung cancer includes medicaments that are specifically well known and marketed after undergoing rigorous clinical trials in affected patients to cause the anti tumor effects and during such therapy, the concerned patient should analyze the symptoms he is experiencing in the lung cancer and should be able to tell clearly the thoracic specialist on wherefrom the sign like the pain factor in the thoracic region and it is to be understood that if the mediastinal lymph node is involved, then the intensity of pain factor will be often greater and is most of the times, intolerable thus warranting immediate medical intervention symptomatically. Hence, during the routine chemotherapy both the affected patient and the attending doctor have to exercise great cautions without leaving the targeted treatment unless it requires so.
Monitoring during chemotherapy
Monitoring is required in-patient receiving multiple drugs given to the lung cancer. This monitoring is essential because of the fact that there are certain medicaments that can affect severely the hepatic system or blood cells in body. Similarly, there are recorded incidences of renal damage by the drugs used under the pretext of chemotherapy for lung cancer. Similarly, the experienced clinical oncologist will be carefully monitoring the patient for presence of any symptoms of affection in nervous system, also.
These type of clinical precautions must be undertaken on a priority basis and the significance of this is because of the accepted fact that though anti- cancerous effects are documented with these chemotherapy for lung cancer, it is equally true that side effects may occur in such patients because of the unexpected and unwarranted signs and symptoms due to their effects on various organs and their metabolites present in serum of the patients undergoing chemotherapy for lung cancer.